Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody
about
The use of (18)F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time.Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragmentsApplications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression and response to therapy in mouse xenograft models of prostate cancer.Improved modeling of in vivo kinetics of slowly diffusing radiotracers for tumor imaging.An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.In vivo imaging with antibodies and engineered fragments.Radioimmunoconjugates for treating cancer: recent advances and current opportunities.Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.Residualization Rates of Near-Infrared Dyes for the Rational Design of Molecular Imaging Agents.The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodiesMinimalist Antibodies and Mimetics: An Update and Recent Applications.Macrocycle-Based Hydroxamate Ligands for Complexation and Immunoconjugation of 89Zirconium for Positron Emission Tomography (PET) Imaging.ImmunoPET of Malignant and Normal B Cells with 89Zr- and 124I-Labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization In Vivo.Engineering a high-affinity peptide binding site into the anti-CEA mAb M5A.Preclinical Optimization of Antibody-based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy - Model, Vector, and Radionuclide Selection.Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.Aligning physics and physiology: Engineering antibodies for radionuclide delivery.
P2860
Q27300759-BBC15206-9018-43CF-8491-79849600B5D7Q30728281-F390B2E3-4283-4A22-B4FD-9ABB03AC049CQ34459696-D3D5F793-CB9E-428B-AB2F-83FE8ABA8F7DQ34717742-FB779CFF-2172-49AA-9C56-3FB6C9B3852EQ35101117-10D5B643-FB23-4EFA-B37C-C3C8D4C16853Q36437102-3859F900-0ABE-4D05-B26B-CA0E3F0A3B55Q36877472-47E6BAD0-E509-4D78-9065-EEB4A90B8A25Q38454458-25442456-D856-45C4-8654-D9769BAA87ADQ38691472-AD3AC58A-8C45-47D8-9780-DD6EBF638910Q38699173-047C3CD7-15FD-431E-892E-670073A86B8DQ38887857-008E6051-6078-4946-9020-00888013BAB2Q38903311-24F25513-1816-48F6-8263-782C61A84ED0Q38914281-27386236-5645-4270-939A-DBA105790F8EQ41067900-0D78774E-77CF-4EED-92ED-2C84C25381CAQ46060208-47E212A8-A229-459C-8026-2C7A4A1E9D29Q47578202-616AC97C-5DA8-4D9F-B442-C05EECB211D9Q48089417-CA65C123-1847-4486-BFAD-41A5829F82EFQ48192595-084DC4C0-16F5-417E-930E-5FBDB8CB7022Q51740406-5F5E3DC6-6A15-4E5D-9C8B-4AF2AA4E98AA
P2860
Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Quantitative immunoPET of pros ...... labeled anti-PSCA A11 minibody
@ast
Quantitative immunoPET of pros ...... labeled anti-PSCA A11 minibody
@en
type
label
Quantitative immunoPET of pros ...... labeled anti-PSCA A11 minibody
@ast
Quantitative immunoPET of pros ...... labeled anti-PSCA A11 minibody
@en
prefLabel
Quantitative immunoPET of pros ...... labeled anti-PSCA A11 minibody
@ast
Quantitative immunoPET of pros ...... labeled anti-PSCA A11 minibody
@en
P2093
P2860
P1476
Quantitative immunoPET of pros ...... labeled anti-PSCA A11 minibody
@en
P2093
David B Stout
Felix B Salazar
Kirstin A Zettlitz
Matthew M Rochefort
Paul J Yazaki
Richard Tavaré
Robert E Reiter
Scott M Knowles
P2860
P304
P356
10.2967/JNUMED.113.120873
P407
P577
2014-02-06T00:00:00Z